102 related articles for article (PubMed ID: 288724)
1. Chromosomal marker 20q- in cases of osteomyelosclerosis and CML.
Fleischman EW; Prigogina EL; Volkova MA; Kulagina OE
Hum Genet; 1979; 50(1):101-4. PubMed ID: 288724
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the del(20q) chromosome in hematologic disorders.
Aatola M; Armstrong E; Teerenhovi L; Borgström GH
Cancer Genet Cytogenet; 1992 Aug; 62(1):75-80. PubMed ID: 1521239
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood cells in the study of chromosome aberrations of patients with chronic myeloid leukaemia or myelofibrosis.
Pakkala A; Ruutu T; Partanen S; Kovanen R; Borgström GH; Knuutila S
Acta Haematol; 1983; 70(4):264-8. PubMed ID: 6414213
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic studies in chronic myeloproliferative disorders.
Carbonell F; Ganser A; Heimpel H
Acta Haematol; 1983; 69(3):145-51. PubMed ID: 6404096
[TBL] [Abstract][Full Text] [Related]
5. Chromosome deletion [46,XX,del(20)(q11)] in agnogenic myeloid metaplasia.
Findley L; Kurnick JE; Peakman DC; Robinson A
Hum Genet; 1979 Mar; 47(2):207-11. PubMed ID: 437786
[TBL] [Abstract][Full Text] [Related]
6. [Chromosomal and cytochemical findings in osteomyelosclerosis].
Müller D; Haberlandt W
Blut; 1970 Apr; 20(4):205-13. PubMed ID: 4315416
[No Abstract] [Full Text] [Related]
7. Deletion of the long arm of chromosome 20 [del(20)(q11)] in myeloid disorders.
Testa JR; Kinnealey A; Rowley JD; Golde DW; Potter D
Blood; 1978 Nov; 52(5):868-77. PubMed ID: 698393
[TBL] [Abstract][Full Text] [Related]
8. A myeloproliferative disorder may hide another one.
Laibe S; Tadrist Z; Arnoulet C; Sainty D; Mozziconacci MJ
Leuk Res; 2009 Aug; 33(8):1133-6. PubMed ID: 19250672
[TBL] [Abstract][Full Text] [Related]
9. Treatment of deletion 5q acute myeloid leukemia with lenalidomide.
Lancet JE; List AF; Moscinski LC
Leukemia; 2007 Mar; 21(3):586-8. PubMed ID: 17230228
[No Abstract] [Full Text] [Related]
10. Significance of chromosomal studies in leukemia: karyotype analysis of 28 cases of leukemia and 2 cases of myelofibrosis.
Yang A; Liu SM; Yan J; Fei HG; Wang BM; Guo J; Zhu SY
Acta Acad Med Wuhan; 1981; 1(2):7-15. PubMed ID: 6962932
[No Abstract] [Full Text] [Related]
11. Transformation of primary myelofibrosis with 20q- in Philadelphia-positive acute lymphoblastic leukemia: case report and review of literature.
Jurisic V; Colovic N; Terzic T; Djordjevic V; Colovic M
Pathol Res Pract; 2012 Jul; 208(7):420-3. PubMed ID: 22658480
[TBL] [Abstract][Full Text] [Related]
12. c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders.
Le Beau MM; Westbrook CA; Diaz MO; Rowley JD
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6692-6. PubMed ID: 2413444
[TBL] [Abstract][Full Text] [Related]
13. Coincidence between fragile site expression and interstitial deletion of chromosome 11 in a case of myelofibrosis.
Sessarego M; Ajmar F; Ravazzolo R; Bianchi Scarrà GL; Garrè C; Boccaccio P
Hum Genet; 1983; 63(3):299-301. PubMed ID: 6852829
[TBL] [Abstract][Full Text] [Related]
14. A FISH comparison of variant derivatives of the recurrent dic(17;20) of myelodysplastic syndromes and acute myeloid leukemia: Obligatory retention of genes on 17p and 20q may explain the formation of dicentric chromosomes.
MacKinnon RN; Patsouris C; Chudoba I; Campbell LJ
Genes Chromosomes Cancer; 2007 Jan; 46(1):27-36. PubMed ID: 17048234
[TBL] [Abstract][Full Text] [Related]
15. Myelofibrosis in myeloid malignancies with 3q26 cytogenetic abnormalities.
Sancho JM; Ribera JM; Granada I; Navarro JT; Millá F; Feliu E
Haematologica; 2000 May; 85(5):554-5. PubMed ID: 10800180
[No Abstract] [Full Text] [Related]
16. The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
Hidaka T; Shide K; Shimoda H; Kameda T; Toyama K; Katayose K; Kubuki Y; Nagata K; Takenaka K; Akashi K; Okamura T; Niho Y; Mizoguchi H; Omine M; Ozawa K; Harada M; Shimoda K
Eur J Haematol; 2009 Oct; 83(4):328-33. PubMed ID: 19549278
[TBL] [Abstract][Full Text] [Related]
17. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).
Wang PW; Iannantuoni K; Davis EM; Espinosa R; Stoffel M; Le Beau MM
Genes Chromosomes Cancer; 1998 Feb; 21(2):75-81. PubMed ID: 9491317
[TBL] [Abstract][Full Text] [Related]
18. Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
Smoley SA; Fink SR; Paternoster SF; Stockero KJ; Nguyen LP; Nguyen PL; Hanson CA; Dewald GW
Cancer Genet Cytogenet; 2007 Mar; 173(2):144-9. PubMed ID: 17321330
[TBL] [Abstract][Full Text] [Related]
19. Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosis.
Buxhofer-Ausch V; Gisslinger H; Berg T; Gisslinger B; Kralovics R
Eur J Haematol; 2009 Feb; 82(2):161-3. PubMed ID: 19018861
[No Abstract] [Full Text] [Related]
20. Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients.
Kurtin PJ; Dewald GW; Shields DJ; Hanson CA
Am J Clin Pathol; 1996 Nov; 106(5):680-8. PubMed ID: 8929482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
